For pharmaceutical companies operating in Europe, staying informed about regulatory pathways is essential for growth and innovation. One such opportunity is the Competitive Generic Therapy program. But what is the Competitive Generic Therapy program, and how can it benefit your organization?
This program supports faster approval of generic medicines that address unmet needs or offer significant public health benefits. By understanding what is the Competitive Generic Therapy program, pharmaceutical manufacturers can strategically position their products and improve market access while contributing to patient care.
Stay ahead in the competitive market—learn how this initiative can drive your generics pipeline.
https://www.pharmafocuseurope.com/articles/the-competitive-generic-therapy-cgt
